🇺🇸 FDA
Patent

US 6686334

Use of inhibitors of protein kinase C epsilon to treat pain

expired A61KA61K38/45

Quick answer

US patent 6686334 (Use of inhibitors of protein kinase C epsilon to treat pain) held by The Regents of the University of California expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/45